Special Issue "Induced Pluripotent Stem Cells in Basic and Translational Research"
Deadline for manuscript submissions: 30 September 2023 | Viewed by 5221
2. Department of Radiology, Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229-3900, USA
Interests: Parkinson’s disease; stroke; traumatic brain injury (TBI); multiple sclerosis (MS); human neural stem cells (NSCs); non human primate studies
Special Issues, Collections and Topics in MDPI journals
The ability to turn adult skin, blood, or other types of somatic cells into a pluripotent stem cell has opened new frontiers in basic biology and medical research. An induced pluripotent stem cell (iPSC) is created by reprogramming any cell of the human body into the pluripotent developmental stage. The reprogrammed cells are then able to generate a virtually unlimited number of progeny capable of differentiating into organ-specific specialized functional cells. IPSCs offer a unique research platform for modeling gene variants and monogenic causal genes to characterize gene-associated function and dysfunction, for drug screening, for cell therapy, and for personalized medicine. This Special Issue focuses on recent advances in iPSC basic and translational research, specifically cellular differentiation, the generation of specific lineages, tissue morphogenesis and 3D culture systems, the pathogenesis of diseases, in vitro systems for drug discovery, and the development of innovative therapeutic interventions.
Dr. Marcel M. Daadi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.